From serving at Ground Zero after September 11th to advancing patient-centered oncology care at Daiichi Sankyo, John Ruggiero shares how resilience, compassion, and purpose shaped his journey into the pharmaceutical industry. As Executive Director, U.S. Medical Affairs, HEOR, he reflects on cancer research, patient empowerment, and the culture that keeps him inspired.
Daiichi Sankyo CARE Teams go above and beyond educating healthcare providers about our medicines and providing patient support. Discover how we CARE...
While our lungs support our very existence, we often don’t recognize that something isn’t quite right with our lung health. Get answers to questions about lung cancer and listen to empowered patients...
Growing up in a Spanish-speaking home, I was the family translator—a role that became particularly challenging when my mother was diagnosed with breast cancer. My family relied on me…
Each patient journey is unique for those faced with a breast cancer diagnosis. At Daiichi Sankyo, we strive to deepen our understanding beyond the scientific aspects, distinguishing between the personal needs of patients with early-stage versus metastatic breast cancer.
Informed patients are empowered patients. Which is why helping people with cancer understand their disease, as well as how available treatment options might work for them, is a critical focus of our patient advocacy efforts.
For cancer patients, the science concerning their disease is sometimes outside of reach. As a patient-centric organization, we are on a mission to break down those barriers.